Literature DB >> 19147255

Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children.

M F C Beersma1, M Schutten, H Vennema, N G Hartwig, T H M Mes, A D M E Osterhaus, G J J van Doornum, M Koopmans.   

Abstract

We report a retrospective analysis of norovirus (NoV) infections occurring in patients of a tertiary care hospital during five winter seasons (2002/03 to 2006/07). Data were compared with national surveillance data and with corresponding data for rotavirus. Between July 2002 and June 2007, faecal specimens from 221 (9.0%) of 2458 hospital patients with diarrhoea tested positive for NoV. The incidence in children varied from 2.52 per 1000 admissions in 2004/05 (when testing began to be performed routinely) to 11.9 per 1000 admissions in 2006/07, while the incidence in adults remained stable (mean: 1.49 per 1000 admissions). Two genotypes predominated during the study period: GIIb strains occurred mainly in children below the age of two-and-a-half years [odds ratio (OR): 14.7; P<0.0001] whereas GII.4 strains affected all age groups. Compared with rotavirus infections, NoV infections in children were more often hospital-acquired (59% vs 39%, OR: 2.29; P<0.01). Among these cases we identified 22 clusters of NoV infection among inpatients. Twelve of 53 patients from whom follow-up samples were available demonstrated long-term virus shedding. We report a dynamic pattern of sporadic NoV infections in large hospitals, with frequent nosocomial transmission and with the predominance of GIIb-related strains in children. Effective prevention strategies are required to reduce the impact of sporadic NoV infection in vulnerable patients.

Entities:  

Mesh:

Year:  2009        PMID: 19147255     DOI: 10.1016/j.jhin.2008.11.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  21 in total

1.  Chronic shedders as reservoir for nosocomial transmission of norovirus.

Authors:  Faizel H A Sukhrie; J Joukje Siebenga; Matthias F C Beersma; Marion Koopmans
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

2.  Genogroup IIb norovirus infections and association with enteric symptoms in a neonatal nursery in southern India.

Authors:  Vipin Kumar Menon; Santosh George; Sasirekha Ramani; Jeyaram Illiayaraja; Rajiv Sarkar; Atanu Kumar Jana; Kurien Anil Kuruvilla; Gagandeep Kang
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

3.  Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France.

Authors:  M Lorrot; F Bon; M J El Hajje; S Aho; M Wolfer; H Giraudon; J Kaplon; E Marc; J Raymond; P Lebon; P Pothier; D Gendrel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-03       Impact factor: 3.267

4.  Infectious disease transmission as a forensic problem: who infected whom?

Authors:  Peter Teunis; Janneke C M Heijne; Faizel Sukhrie; Jan van Eijkeren; Marion Koopmans; Mirjam Kretzschmar
Journal:  J R Soc Interface       Date:  2013-02-06       Impact factor: 4.118

5.  Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age.

Authors:  Tammy Bui; Jacob Kocher; Yanru Li; Ke Wen; Guohua Li; Fangning Liu; Xingdong Yang; Tanya LeRoith; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Gen Virol       Date:  2013-06-26       Impact factor: 3.891

Review 6.  Advances in norovirus biology.

Authors:  Stephanie M Karst; Christiane E Wobus; Ian G Goodfellow; Kim Y Green; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

7.  Norovirus in health care and implications for the immunocompromised host.

Authors:  Pearlie P Chong; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

8.  The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.

Authors:  J Rocha-Pereira; M S J Nascimento; Q Ma; R Hilgenfeld; J Neyts; D Jochmans
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

9.  Inactivation of murine norovirus by chemical biocides on stainless steel.

Authors:  Thomas Magulski; Dajana Paulmann; Birte Bischoff; Britta Becker; Eike Steinmann; Jörg Steinmann; Peter Goroncy-Bermes; Jochen Steinmann
Journal:  BMC Infect Dis       Date:  2009-07-07       Impact factor: 3.090

10.  Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom.

Authors:  Nigel A Cunliffe; J Angela Booth; Claire Elliot; Sharon J Lowe; Will Sopwith; Nick Kitchin; Osamu Nakagomi; Toyoko Nakagomi; C Anthony Hart; Martyn Regan
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.